| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Mar 27, 2020New Offerings Available to Existing Medtronic Care Management Services Customers as well as New Hospital Systems, Health Plans and Employers
DUBLIN, March 27, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced its Medtronic Care Management Services (MCMS) business is launching...
-
Feb 24, 2020Positive Data on Many Medtronic Innovations Presented at ATTD: Extended Wear Infusion Set Designed to Last Twice as Long, MiniMed™ 670G System Real-Life Performance in Europe, and ProCGM Use in Type 2 Diabetes Patients
DUBLIN, Feb. 24, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced a successful conclusion to the 13th International Conference on...
-
Feb 18, 2020Revenue of $7.7 Billion Increased 2.3% Reported and 2.6% Organic
DUBLIN, Feb. 18, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) today announced financial results for its third quarter of fiscal year 2020, which ended January 24, 2020. The company reported...
-
Jan 30, 2020Next Generation Technology Includes Features that Automatically Adjust to Patient Needs, and Offers Physicians Heart Failure Diagnostic Insights
DUBLIN, Jan. 30, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) today announced it has received CE (Conformité Européenne) Mark for its Cobalt™ and Crome™ portfolio of implantable...
-
Jan 23, 2020Efficio Software Provides Enhanced, Secure Access to Patient Data and Delivers
DUBLIN, Jan. 23, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) today announced the launch of Efficio™, a cloud-based data management software for use with the SynchroMed™ II intrathecal...
-
Jan 21, 2020With FDA Approval, More Patients in the U.S. Are Now Candidates for a Leadless Pacing Option
DUBLIN, Jan. 21, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) today announced it has received U.S. Food and Drug Administration (FDA) approval of Micra™ AV, the world’s smallest pacemaker...
-
Jan 9, 2020This Next-Generation DBS Technology Allows Physicians to Review Patient-Specific Brain Signals, Enabling More Personalized, Data-Driven Neurostimulation Treatment for Patients
DUBLIN, Jan. 09, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) today announced the CE (Conformité Européenne) Mark for Percept™ PC neurostimulator; it is the only Deep Brain Stimulation...
-
Nov 19, 2019Revenue of $7.7 Billion Increased 3.0% Reported and 4.1% Organic
DUBLIN, Nov. 19, 2019 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) today announced financial results for its second quarter of fiscal year 2020, which ended October 25, 2019. The company reported...
-
Oct 31, 2019Lower-Profile Thoracic Endovascular Aortic Repair (TEVAR) Device Continues to Broaden Global Treatable Patient Population with Thoracic Aortic Disease
DUBLIN, Oct. 31, 2019 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) today announced Shonin approval from the Ministry of Health, Labour and Welfare (MHLW) and the launch of the Valiant Navion™...
-
Oct 30, 2019System Offers at Home Therapy Management for DBS patients Using Patient-Friendly Consumer Technology
DUBLIN and SAN JOSE, Calif., Oct. 30, 2019 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) today announced the U.S. launch of its advanced Patient Programmer technology for Deep Brain Stimulation...
-
Oct 17, 2019The GI Genius™ Intelligent Endoscopy Module Transforms Colorectal Cancer Detection Benefitting Patients and Gastroenterologists
DUBLIN and BARCELONA, Spain, Oct. 17, 2019 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the launch of GI Genius™ intelligent endoscopy...
-
Sep 24, 2019Delivers the Industry’s Most Complete Portfolio of Implants, Biologics, Imaging, Navigation, Robotics, and Surface Technologies Designed to Transform Spine Outcomes
DUBLIN and CHICAGO, Sept. 24, 2019 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) today announced the launch of several new procedural solutions for spine surgery, further reinforcing the...
-
Sep 23, 2019Improved Functionality Across Four Valve Sizes and Lowest Delivery Profile on the Market, the Evolut PRO+ TAVR System Launches in U.S. as TAVR Patient Population Grows
DUBLIN, Sept. 23, 2019 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), a global leader in heart valve therapies, today announced U.S. Food and Drug Administration (FDA) approval and U.S. launch of...
-
Sep 17, 2019Next-Generation Professional CGM Combines Valuable Data with Optimal User Experience
DUBLIN, Sept. 17, 2019 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, services and solutions, today announced the Envision™ Pro Continuous Glucose...
-
Sep 16, 2019The New Collaboration Aims to Develop Solutions Enabling Dosing Data from Novo Nordisk Smart Insulin Pens to be Shared with Medtronic Continuous Glucose Monitoring Devices
DUBLIN and BAGSVÆRD, Denmark, Sept. 16, 2019 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), and Novo Nordisk A/S today announced a collaboration that will develop solutions to integrate insulin...
-
Sep 13, 2019Strong ESG Practices Results in Inclusion on North American Dow Jones Sustainability Index (DJSI) for Twelfth Consecutive Year
DUBLIN, Sept. 13, 2019 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) today announced that it has been recognized as one of the world's leading companies for sustainability with its inclusion in the...
-
Aug 28, 2019Omar Ishrak Will Retire as CEO at End of Fiscal Year; Remains Chairman of the Board and Becomes Executive Chairman of Medtronic
DUBLIN, Aug. 28, 2019 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) today announced that Omar Ishrak, Medtronic’s Chairman and Chief Executive Officer (CEO), has announced his intention to retire...
-
Aug 20, 2019Revenue of $7.5 Billion Increased 1.5% Reported; Increased 3.5% Constant Currency
DUBLIN, Aug. 20, 2019 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) today announced financial results for its first quarter of fiscal year 2020, which ended July 26, 2019. The company reported...
-
Jul 23, 2019
DUBLIN, July 23, 2019 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), the global leader in medical technology, services and solutions, today announced its Premarket Approval (PMA) submission to the...
-
Jul 8, 2019Company Plans Global Registry of HVAD Thoracotomy Implants to Advance Therapy Knowledge
DUBLIN, July 08, 2019 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) today announced two-year outcomes from the LATERAL clinical trial evaluating the use of its HeartWare™ HVAD™ System in...
-
Jun 27, 2019Acquisition Accelerates Medtronic’s Strategy to Transform Spinal Procedures and Improve Outcomes Through Complete Procedural Solutions
DUBLIN, June 27, 2019 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT), a global leader in medical technology, today announced it has completed the acquisition of Titan Spine, a privately-held...
-
May 29, 2019
DUBLIN - May 29, 2019 - Medtronic plc (NYSE:MDT) today announced U.S. Food and Drug Administration (FDA) clearance and commercial launch for the SelectSite(TM) C304-HIS deflectable catheter system...
-
May 28, 2019
DUBLIN - May 28, 2019 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced real-world clinical outcomes for the MiniMed(TM) 670G system, which is being used by more...
-
May 23, 2019Q4 Revenue of $8.1 Billion, Flat as Reported and Grew 3.6% Organic
DUBLIN - May 23, 2019 - Medtronic plc (NYSE:MDT) today announced financial results for its fiscal year and fourth quarter 2019, which ended April 26, 2019. Medtronic's fiscal year 2019 revenue of...
-
May 16, 2019FDA Cleared and CE Marked, Telescope Enters Global Market with Design Innovations to Enable Smooth Delivery of Coronary Stents and Balloons
DUBLIN - May 16, 2019 - Medtronic plc (NYSE:MDT), a global leader in percutaneous coronary intervention (PCI) innovation, today announced its entrance into the guide extension catheter market with...
-
May 2, 2019Tablet-Based Device Manager Provides Portable and Secure Wireless Programming of Medtronic BlueSync(TM) Devices
DUBLIN - May 2, 2019 - Medtronic plc (NYSE:MDT) today announced that the company has received U.S. Food and Drug Administration (FDA) approval for the CareLink SmartSync(TM) Device Manager. With...
-
Apr 30, 2019System Offers New Options for Improving Outcomes in Treating Stroke; World's Second-Leading Cause of Death, Third-Leading Cause of Disability
DUBLIN - April 30, 2019 - Medtronic plc (NYSE:MDT) today announced the U.S. launch of the Solitaire(TM) X Revascularization Device - and its first use in patients for the treatment of acute...
-
Mar 16, 2019Less Invasive Evolut™ Transcatheter Aortic Valve Replacement (TAVR) System Successful in Clinical Trial When Compared to Open Heart Surgery in Healthier Aortic Stenosis Patients
DUBLIN and NEW ORLEANS – March 16, 2019 – Medtronic plc (NYSE:MDT) today announced first-ever clinical data from the landmark Evolut Low Risk Trial comparing the minimally invasive Evolut™...
-
Feb 28, 2019Grafton(TM) DBM Product Will Provide More Options for Spine and Orthopedic Surgeons in Japan
DUBLIN and TOKYO - February 28, 2019 - Medtronic plc (NYSE:MDT) announced today the Japanese launch of the Grafton(TM) Demineralized Bone Matrix (DBM) bone grafting product for spine and...
-
Feb 27, 2019Medtronic Expands Pain Portfolio with Minimally Invasive Therapy to Support Patients Throughout the Care Continuum
DUBLIN - February 27, 2019 - Medtronic plc (NYSE:MDT) today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the Accurian(TM) RF ablation platform, which conducts radio...
-
Feb 20, 2019With Official Launch and First Implant, Several Health Insurers Now Consider DBS Therapy for Epilepsy a Covered Indication
DUBLIN - February 20, 2019 - Medtronic plc (NYSE:MDT) today announced both the U.S. launch of Deep Brain Stimulation (DBS) for medically-refractory epilepsy and the first commercially implanted...
-
Feb 19, 2019Revenue of $7.5 Billion Increased 2.4% Reported; Increased 4.4% Organic
DUBLIN - February 19, 2019 - Medtronic plc (NYSE: MDT) today announced financial results for its third quarter of fiscal year 2019, which ended January 25, 2019. The company reported third quarter...
-
Jan 30, 2019Company Is Committed to Leading Evidence Generation Across the Lung Cancer Care Continuum
DUBLIN - January 30, 2019 - Medtronic plc (NYSE:MDT) today announced that the Journal of Thoracic Oncology has published 12-month results of the NAVIGATE study, the largest, prospective,...
-
Jan 28, 2019First U.S. Patients Treated Using Mazor X Stealth(TM) Edition at Norton Healthcare and Reston Hospital Center
DUBLIN - January 28, 2019 - Medtronic plc (NYSE:MDT) today announced the first U.S. patients treated with the Mazor X Stealth(TM) Edition for spine surgery following its recent commercial launch....
-
Jan 17, 2019Study Will Further Advance Understanding of Effectiveness and Tolerability of the SynchroMed(TM) II Intrathecal Drug Delivery System in Patients Who Have Weaned off Oral Opioids
DUBLIN - January 17, 2019 - Medtronic plc (NYSE:MDT) today announced the first patient enrolled in the Embrace TDD (targeted drug delivery) clinical study that will evaluate the use of the...
-
Jan 15, 2019MyCareLink Heart(TM) Mobile App Allows Pacemaker Patients to Easily Stay Connected with Their Clinics
DUBLIN - January 15, 2019 - Medtronic plc (NYSE:MDT) today announced the launch of its MyCareLink Heart(TM) mobile app to support the world's first and only portfolio of pacemakers that can...
-
Jan 9, 2019Program Celebrates the Legacy of Medtronic Co-Founder Earl Bakken and Other Outstanding Patient Advocates Around the World
MINNEAPOLIS and Kona, Hawaii - January 9, 2019 - The Medtronic Foundation today announced 12 individuals from around the world as recipients of the 2018 Bakken Invitation. This Medtronic...
-
Dec 10, 2018
DUBLIN - December 10, 2018 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has been named one of America's Most JUST Companies in 2018, according to Forbes...
-
Nov 20, 2018Revenue of $7.5 Billion Increased 6.1% Reported; Increased 7.5% Organic
DUBLIN - November 20, 2018 - Medtronic plc (NYSE: MDT) today announced financial results for its second quarter of fiscal year 2019, which ended October 26, 2018. The company reported second...
-
Oct 21, 2018
DUBLIN - October 21, 2018 - Medtronic plc (NYSE:MDT) announced today that its co-founder, Earl E. Bakken, passed away peacefully on October 21, 2018 at his home on Kiholo Bay on the Big Island of...
-
Oct 16, 2018
(GLOBE NEWSWIRE via COMTEX) --For Use with SynchroMed(TM) II Intrathecal Drug Delivery System, the Control WorkflowAims to Effectively Address Chronic Pain Without the Use of Oral Opioids DUBLIN -...
-
Sep 25, 2018
GLOBE NEWSWIRE via COMTEX) --System is Fully Integrated with Medtronic's Market-Leading Imaging and Navigation Technology to Transform Posterior Cervical Spine Surgery DUBLIN and LOS ANGELES -...
-
Sep 24, 2018
(GLOBE NEWSWIRE via COMTEX) --TCT18: New Five-Year Data with CoreValve TAVR System Suggests Durability Over Time, While Complete Results from the SURTAVI Trial Show Benefits of TAVR in...
-
Sep 20, 2018Acquisition to Accelerate Medtronic's Strategy to Transform Spinal Procedures and Improve Outcomes Through Fully-Integrated Surgical Solutions
DUBLIN and CAESAREA, Israel - September 20, 2018 - Medtronic plc (NYSE:MDT), a global leader in medical technology, and Mazor Robotics (NASDAQ:MZOR, TASE:MZOR.TZ), a pioneer in the field of...
-
Sep 18, 2018
(GLOBE NEWSWIRE via COMTEX) --Medtronic Receives FDA Approval for Revised TAVR Labeling and Begins Investigational Study of Low Risk Patients with Bicuspid Valves DUBLIN - September 18, 2018 -...
-
Sep 17, 2018
(GLOBE NEWSWIRE via COMTEX) --Medtronic CEO Omar Ishrak Commits to Continue Accelerating Diversity, Inclusion and Gender Equality DUBLIN - September 17, 2018 - Medtronic plc (NYSE:MDT) today...
-
Sep 13, 2018
(GLOBE NEWSWIRE via COMTEX) --Company Marks its Eleventh Consecutive Year on the North American Dow Jones Sustainability Index (DJSI) DUBLIN - September 13, 2018 - Medtronic plc (NYSE:MDT) was...
-
Aug 21, 2018(GLOBE NEWSWIRE via COMTEX) --- Revenue of $7.4 Billion Decreased 0.1% Reported; Increased 6.8% Organic
DUBLIN - August 21, 2018 - Medtronic plc (NYSE: MDT) today announced financial results for its first quarter of fiscal year 2019, which ended July 27, 2018. The company reported first quarter...
-
Aug 15, 2018
GLOBE NEWSWIRE via COMTEX) --DUBLIN - August 15, 2018 - Medtronic plc (NYSE:MDT) today announced full commercial launch of the IN.PACT(TM) Admiral(TM) Drug-Coated Balloon (DCB) in Japan. The news...
-
Aug 9, 2018
GLOBE NEWSWIRE via COMTEX) --DUBLIN - August 9, 2018 - Medtronic today announced the official U.S. launch of the Medtronic Inner CircleSM patient engagement program, which uses gamification - the...
-
Jul 10, 2018First-Year Results Demonstrate a 27 Percent Decline in Rate of Preventable Hospital Admissions for Medtronic Insulin Pump Users Compared to Patients on Multiple Daily Injections of Insulin
DUBLIN - July 10, 2018 - Medtronic plc (NYSE:MDT) and UnitedHealthcare today announced first year results from an innovative value-based relationship focused on delivering patient-centered...
-
Jun 28, 2018
GLOBE NEWSWIRE via COMTEX) --DUBLIN- June 28, 2018 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the launch of the MiniMed(TM) 670G Performance Guarantee...
-
Jun 24, 2018
GLOBE NEWSWIRE via COMTEX) --DUBLIN - June 24, 2018 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced real-world clinical outcomes for 32,178 users of the...
-
Jun 19, 2018(GLOBE NEWSWIRE via COMTEX) --Medtronic Will Host a Webcast of Its Diabetes Group Analyst and Investor Briefing on Monday, June 25 from 9 - 10 a.m. EDT
DUBLIN - June 19, 2018 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced its schedule of notable sessions that will be presented at the 78th Scientific Sessions...
-
Jun 13, 2018FDA Approved, DBS Clinician Programmer Optimizes the Programming Experience By Addressing Day-to-Day Clinical Management Challenges
DUBLIN - June 13, 2018 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that the U.S. Food and Drug Administration (FDA) recently approved its state-of-the art...
-
May 24, 2018Onyx 1-Month OCT Study Provides Potential Insights on DAPT Duration in Complex Patients Following Stent Implantation
DUBLIN and PARIS- May 24, 2018 - Investigators today unveiled clinical data from the independently run Onyx 1-Month OCT Study, which showed strong early vessel healing in a patient population that...
-
May 24, 2018Q4 Revenue of $8.1 Billion Grew 2.9% Reported and 6.5% Organic
DUBLIN - May 24, 2018 - Medtronic plc (NYSE: MDT) today announced financial results for its fourth quarter and fiscal year 2018, which ended April 27, 2018. The company reported fourth quarter...
-
May 1, 2018Medtronic Receives FDA Approval for Deep Brain Stimulation Therapy for Medically Refractory Epilepsy7-Year Data from the SANTE Trial Showed Median Seizure Frequency Reduction of 75 percent in Patients with Drug-Resistant Epilepsy with Partial-Onset Seizures Receiving DBS Therapy.
DUBLIN - May 1, 2018 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that the U.S. Food and Drug Administration (FDA) has granted premarket approval for Medtronic'
-
May 1, 2018Medtronic Announces TiONIC(TM) Technology, a Titanium 3D Printed Platform for Spine Surgery ImplantsTechnology Allows for Creation of More Intricate Implant Designs and Surface Textures
DUBLIN and NEW ORLEANS - May 1, 2018 - Medtronic plc (NYSE: MDT) today announced the launch of a titanium 3D printed platform - TiONIC(TM) Technology - that enables more complex designs and...
-
Apr 17, 2018Product Line Offers Unique, Resorbable Option for Patients with Hypervascular Tumors
DUBLIN - April 17, 2018 - Medtronic plc (NYSE: MDT) today announced its U.S. launch of OptiSphere(TM) embolization spheres, a resorbable embolic platform designed for embolization of hypervascular...
-
Apr 10, 2018
DUBLIN - April 10, 2018 - Medtronic plc (NYSE: MDT) announced today the CE (Conformité Européenne) Mark and European launch of the Visualase(TM) MRI-Guided Laser Ablation System. The Visualase...
-
Mar 10, 2018Presented at ACC.18, Five-Year Follow-up from the CoreValve Extreme Risk and NOTION Studies Show Sustained Valve Function and Durability Over Time
DUBLIN and ORLANDO - March 10, 2018 - Medtronic plc (NYSE: MDT) today unveiled outcomes from the CoreValve U.S. Pivotal Extreme Risk Study and the real-world NOTION trial (Nordic Aortic Valve...
-
Feb 26, 2018FDA Approved, Resolute Onyx 2.0 mm DES Technology Tackles Clinical Challenge of Treating Coronary Artery Disease in Previously Untreatable Patients
DUBLIN - February 26, 2018 - Designed specifically for small vessels, Medtronic plc (NYSE: MDT) today announced the U.S. Food and Drug Administration (FDA) approval and U.S. launch of the Resolute...
-
Feb 21, 2018New Infusion Set Offers Simpler, Faster, and More Convenient1 Insulin Pump Experience
DUBLIN - February 21, 2018 - Medtronic plc (NYSE:MDT), the global leader in medical technology, services and solutions, today introduced the MiniMed(TM) Mio(TM) Advance infusion set. The MiniMed...
-
Feb 20, 2018Revenue of $7.4 Billion Increased 1% as Reported; 7% at Comparable, Constant Currency
DUBLIN - February 20, 2108 - Medtronic plc (NYSE: MDT) today announced financial results for its third quarter of fiscal year 2018, which ended January 26, 2018. The company reported third quarter...
-
Jan 30, 2018Data Presented at LINC 2018 Highlight IN.PACT Admiral as Safe and Effective Treatment Option in PAD
DUBLIN and LEIPZIG - January 30, 2018 - Medtronic plc (NYSE: MDT) today added to its robust body of clinical evidence supporting the IN.PACT(TM) Admiral(TM) drug-coated balloon (DCB) with new...
-
Jan 26, 2018Study to Enroll Subjects at up to 35 Sites Across the U.S. and Europe
DUBLIN - January 26, 2018 - Medtronic plc (NYSE: MDT) today announced the initiation of its investigational device exemption (IDE) study for the Abre(TM) venous self-expanding stent system. The...
-
Jan 24, 2018Clinical Study to Investigate the Performance of the ChEVAR Technique in AAA Patients with Short Aortic Necks
DUBLIN - January 24, 2018 - Medtronic plc (NYSE: MDT) today announced the launch of the ENCHANT (ENdurant CHEVAR New Indication Trial) study. The post-market, non-interventional, multi-center,...
-
Nov 27, 2017Medtronic Care Management Services Delivers on Its Commitment to Serve Veteran Patients with Expanded Suite of Telehealth Solutions
DUBLIN - November 27, 2017 - Medtronic plc (NYSE:MDT) today announced its Medtronic Care Management Services (MCMS) business commenced launch of new telehealth solutions in support of its national...
-
Nov 21, 2017Revenue of $7.1 Billion; GAAP Diluted EPS of $1.48; Non-GAAP Diluted EPS of $1.07
DUBLIN - November 21, 2017 - Medtronic plc (NYSE: MDT) today announced financial results for its second quarter of fiscal year 2018, which ended October 27, 2017. The company reported second...
-
Nov 20, 2017Azure(TM) with BlueSync(TM) Technology Improves Device Longevity and Provides Automatic, Wireless Remote Patient Monitoring
DUBLIN - November 20, 2017 - Medtronic plc (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) approval and U.S. commercial launch for its portfolio of Azure(TM) pacemakers with...
-
Nov 6, 2017New Neurostimulation System Is a Non-Opioid Alternative for Chronic Pain and Offers Personalized Pain Relief and Advanced Activity Tracking
DUBLIN - November 6, 2017 - Medtronic plc (NYSE:MDT) today announced that it received CE (Conformité Européenne) Mark for the Intellis(TM) platform for both Spinal Cord Stimulation (SCS) and...
-
Nov 2, 2017Report Highlights Company's Global Financial, Social, and Environmental Impact
DUBLIN - November 2, 2017 - Medtronic plc (NYSE:MDT) announces the release of its fiscal year 2017 Integrated Performance Report. The report highlights the combined financial, social, and...
-
Oct 6, 2017
DUBLIN - October 6, 2017 - Medtronic plc (NYSE: MDT) today provided an update on the impact to its manufacturing and sales operations as a result of Hurricane Maria. All four of the company's...
-
Sep 18, 2017The Intellis Platform Includes the World's Smallest Implantable Spinal Cord Stimulator and Offers Personalized Pain Relief and Advanced Activity Tracking
DUBLIN - September 18, 2017 - Medtronic plc (NYSE:MDT) today announced FDA approval and U.S. launch of the Intellis(TM) platform for the management of certain types of chronic intractable pain....
-
Sep 12, 2017New Platform to Offer Enhanced Visualization and Increased Efficiency for Surgery of the Sinuses and Skull Base
DUBLIN - September 12, 2017 - Medtronic plc (NYSE: MDT) today announced the global launch of the StealthStation(TM) ENT, a new surgical navigation system designed for surgeons treating conditions...
-
Sep 8, 2017Medtronic Announces Japanese Regulatory Approval for the IN.PACT(TM) Admiral(TM) Drug-Coated BalloonClinically-Proven, Durable, Consistent, and Safe Market-Leading DCB Poised to Improve Outcomes for PAD Patients in Japan
DUBLIN - September 8, 2017 - Medtronic plc (NYSE: MDT) today announced that the IN.PACT(TM)Admiral(TM) Drug-Coated Balloon (DCB) received approval from the Japanese Ministry of Health, Labour and...
-
Sep 7, 2017Company Marks a Decade on the North American Dow Jones Sustainability Index (DJSI)
DUBLIN - September 7, 2017 - Medtronic plc (NYSE: MDT) was recognized today as one of the world's leading companies for sustainability with its ranking on the Dow Jones Sustainability North...
-
Sep 5, 2017First Patient Enrolled in Initial Posterolateral Fusion Study
DUBLIN - September 5, 2017 - Medtronic plc (NYSE: MDT) today announced the launch of a long term clinical study program to collect prospective data on INFUSE® Bone Graft in Posterolateral Fusion...
-
Aug 22, 2017Revenue of $7.390 Billion Grew 3% as Reported; 4% at Constant Currency
DUBLIN - August 22, 2017 - Medtronic plc (NYSE: MDT) today announced financial results for its first quarter of fiscal year 2018, which ended July 28, 2017. The company reported first quarter...
-
Aug 21, 2017Medtronic Receives CE Mark for Attain Stability(TM) Quad MRI SureScan(TM) Active-Fixation Heart LeadClinical Trial Also Underway in U.S., Canada and Other Geographies
DUBLIN - August 21, 2017 - Medtronic plc (NYSE: MDT) announced it has received CE (Conformité Européene) Mark for the Attain Stability(TM) Quad MRI SureScan(TM) left heart lead. Paired with...
-
Jul 31, 2017
DUBLIN - July 31, 2017 - Medtronic plc (NYSE:MDT) today announced CE (Conformité Européenne) mark and European launch of the CoreValve(TM)Evolut(TM) PRO valve for the treatment of severe aortic...
-
Jun 7, 2017The MiniMed(TM) 670G System Features the Company's Most Advanced SmartGuard(TM)HCL Technology and New Guardian(TM) Sensor 3
DUBLIN - June 7, 2017 - Medtronic plc (NYSE:MDT), today announced the U.S. launch of the MiniMed(TM) 670G system - the world's first Hybrid Closed Loop system for people with type 1 diabetes....
-
May 31, 2017
DUBLIN - May 31, 2017 - Medtronic plc (NYSE: MDT) recently launched PRODIGY, a 1,650-patient global study, to identify individuals at high risk for opioid induced respiratory depression (OIRD), a...
-
May 25, 2017Q4 Revenue of $7.9 Billion Grew 5% as Reported; 5% at Constant Currency
DUBLIN - May 25, 2017 - Medtronic plc (NYSE: MDT) today announced financial results for its fourth quarter and fiscal year 2017, which ended April 28, 2017. The company reported fourth quarter...
-
May 1, 2017Engineered for Exceptional Deliverability, Advanced DES Technology Features Thinner Struts, Enhanced Visibility and the Broadest Size Matrix in the U.S.
DUBLIN – May 1, 2017 – Medtronic plc (NYSE: MDT) today announced the U.S. Food and Drug Administration (FDA) approval and U.S. launch of the Resolute Onyx™ Drug-Eluting Stent (DES). The...
-
Apr 24, 2017New Platform to Offer Flexibility, Ease of Use, Improved Registration and Advanced Visualization for Custom Procedural Workflows
DUBLIN and LOS ANGELES - April 24, 2017 - Medtronic plc (NYSE:MDT) today launched its new StealthStation(TM) technology at the American Academy of Neurological Surgeons (AANS) annual conference in...
-
Apr 13, 2017Data from Garmin vívofit® Series Now Syncs to Medtronic Care Management Services NetResponse® Mobile Application to Help Track Patient Health at Home
DUBLIN and OLATHE, Kan. - April 13, 2017 - Medtronic plc (NYSE:MDT), the global leader in medical technology, and Garmin International Inc., a unit of Garmin Ltd. (NASDAQ: GRMN), today announced...
-
Mar 21, 2017First-Ever Data at ACC.17 Confirms Safety and Efficacy of New Self-Expanding, Recapturable Heart Valve at 30-Days with High Survival, Low Stroke and Minimal Paravalvular Leak
DUBLIN - March 22, 2017 - Medtronic plc (NYSE:MDT) today announced U.S. Food and Drug Administration (FDA) approval and U.S. launch of the CoreValve(TM) Evolut(TM) PRO valve for the treatment of...
-
Mar 17, 2017Late-Breaking SURTAVI Pivotal Clinical Trial Presented at ACC.17 and Published in NEJM Meets Primary Endpoint at Two Years
DUBLIN and WASHINGTON, D.C. - March 17, 2017 - Medtronic plc (NYSE: MDT) today unveiled first-ever clinical data from the Surgical Replacement and Transcatheter Aortic Valve Implantation (SURTAVI)...
-
Mar 14, 2017Newly Approved Indication in U.S. Expands Treatment Options to More Patients with Congenital Heart Disease
DUBLIN - March 14, 2017 - Medtronic plc (NYSE: MDT) today announced that its Melody(TM)Transcatheter Pulmonary Valve (TPV) received approval from the United States Food and Drug Administration...
-
Mar 9, 2017First Procedure in Prospective, Randomized, Multi-Center Study Performed at Maria Cecilia Hospital in Italy
DUBLIN - Mar. 9, 2017 - Medtronic plc (NYSE: MDT) today announced the launch of the IN.PACT(TM) BTK study to evaluate the effectiveness of using a drug-coated balloon (DCB) in patients with...
-
Feb 21, 2017Revenue of $7.3 Billion Grew 5% as Reported; 6% at Constant Currency
DUBLIN - February 21, 2017 - Medtronic plc (NYSE: MDT) today announced financial results for its third quarter of fiscal year 2017, which ended January 27, 2017. The company reported third quarter...
-
Feb 13, 2017Full Line of Innovative Transradial Products and Comprehensive Training Programs Reinforce Medtronic's Commitment to Optimizing the Treatment of Heart Disease
DUBLIN - Feb. 13, 2017 - Medtronic plc (NYSE: MDT) today announced that its market-leading coronary portfolio will now include the DxTerity Diagnostic Angiography Catheter line and several...
-
Feb 13, 2017Introduces New Approach to Healthcare Education and Development Focused on Outcomes That Matter to Patients
DUBLIN - Feb. 13, 2017 - Medtronic today announced the launch of Medtronic Impact in its Europe, Middle East & Africa region, which is part of the company's drive towards value-based healthcare...
-
Jan 17, 2017Larger Device Offers Treatment to Patients Without a Previous TAVI Option
DUBLIN - Jan. 17, 2017 - Medtronic plc (NYSE:MDT) today announced the CE (Conformité Européenne) mark and European launch of the CoreValve(TM) Evolut(TM) R 34 mm valve-the largest sized...
-
Dec 1, 2016Medtronic Introduces First-and-Only Recapturable TAVI System Available in Japan
DUBLIN - Dec. 1, 2016 - Medtronic plc (NYSE: MDT) today announced it has received reimbursement approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) for the recapturable,...
-
Nov 29, 2016New Agreement Focuses on Improved System Efficiency at University Hospitals Cleveland Medical Center
DUBLIN and CLEVELAND - Nov. 29, 2016 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the signing of its first Integrated Health Solutions agreement in the...
-
Nov 22, 2016Revenue of $7.3 Billion Grew 4% as Reported; 3% at Constant Currency
DUBLIN - November 22, 2016 - Medtronic plc (NYSE: MDT) today announced financial results for its second quarter of fiscal year 2017, which ended October 28, 2016. The company reported second...
-
Nov 10, 2016Orthopedic Solutions Offers Comprehensive Services for Joint Replacement Episodes of Care, Including the Launch of a Total Knee Arthroplasty System
DUBLIN and DALLAS - Nov. 10, 2016 - Medtronic plc (NYSE: MDT) today announced the launch of Medtronic Orthopedic Solutions, a comprehensive offering for total joint replacement episodes of care...